Page 1 of Clinical Trials for tiotropium, 196 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea
Last Updated: March 29, 2010
Condition(s): Chronic Obstructive Pulmonary Disease
2
Completed
Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers
Last Updated: November 16, 2011
Condition(s): Healthy
3
Completed
Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During Exercise
Last Updated: October 20, 2009
Condition(s): COPD
4
Completed
Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: February 21, 2012
Condition(s): Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema
5
Completed
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: July 22, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
6
Completed
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: August 23, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
7
Completed
A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
Last Updated: February 8, 2012
Condition(s): Asthma
8
Recruiting
Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China
Last Updated: January 18, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
9
Completed
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
Last Updated: January 12, 2010
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Pulmonary Emphysema
10
Recruiting
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
Last Updated: March 11, 2012
Condition(s): Asthma
11
Completed
Dynamic Hyperinflation and Tiotropium
Last Updated: June 19, 2009
Condition(s): COPD
12
Completed
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: May 11, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Completed
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
Last Updated: May 11, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
14
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
Last Updated: May 2, 2012
Condition(s): Asthma
15
Recruiting
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Recruiting
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
17
Recruiting
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
18
Recruiting
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
19
Recruiting
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: May 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
20
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=tiotropium

Page 1 of Clinical Trials for tiotropium, 196 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About